Physician profile
Katie Nemirovsky
NPI 1619391349
$711.20
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $304 · 2023: $299 · 2024: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $408.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $407.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $303.51 | 2019 | |
| Biolase, INC. | $150.25 | 2023 | Waterlase Iplus |
| Straumann USA LLC | $108.87 | 2024 | |
| Orapharma, A Division of Bausch Health US, LLC | $77.00 | 2023 | Arestin |
| 3m Company | $37.92 | 2023 | 3m Espe Filtek Supreme Ultra Universal Restorative |
| Ultradent Products INC | $17.63 | 2023 | Opalescence |
| Voco America INC. | $16.02 | 2023 | Admira Fusion X-Tra, Remin Pro, Profluorid L |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katie Nemirovsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.